Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D4VZ2A
|
|||
| Drug Name |
TT-00420
|
|||
| Synonyms |
UNII-WZ9TJ0L9Y8; WZ9TJ0L9Y8; SCHEMBL20266964; CC1=C2N=C(c3ccccc3Cl)c3cnc(cc3N=C2NN1)N1CCOCC1; 2230490-29-4; Pyrazolo(4,3-b)pyrido(4,3-E)(1,4)diazepine, 5-(2-chlorophenyl)-1,2-dihydro-3-methyl-8-(4-morpholinyl)-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [1] | |
| Company |
TransThera Biosciences
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H19ClN6O
|
|||
| Canonical SMILES |
CC1=C2C(=NN1)NC3=CC(=NC=C3C(=N2)C4=CC=CC=C4Cl)N5CCOCC5
|
|||
| InChI |
1S/C20H19ClN6O/c1-12-18-20(26-25-12)23-16-10-17(27-6-8-28-9-7-27)22-11-14(16)19(24-18)13-4-2-3-5-15(13)21/h2-5,10-11H,6-9H2,1H3,(H2,23,25,26)
|
|||
| InChIKey |
DQFCVOOFMXEPOC-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 2230490-29-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03654547) Safety of TT-00420 Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.